ETrade Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $396K | Buy |
30,350
+1,112
| +4% | +$14.5K | 0.01% | 633 |
|
|
2020
Q2 | $332K | Buy |
29,238
+10,840
| +59% | +$123K | 0.01% | 634 |
|
|
2020
Q1 | $264K | Buy |
+18,398
| New | +$264K | 0.01% | 627 |
|
|
2014
Q2 | – | Sell |
-1,683
| Closed | -$58K | – | 602 |
|
|
2014
Q1 | $58K | Sell |
1,683
-2,770
| -62% | -$95.5K | ﹤0.01% | 547 |
|
|
2013
Q4 | $94K | Buy |
4,453
+1,181
| +36% | +$24.9K | 0.01% | 386 |
|
|
2013
Q3 | $77K | Sell |
3,272
-277
| -8% | -$6.52K | 0.01% | 371 |
|
|
2013
Q2 | $95K | Buy |
+3,549
| New | +$95K | 0.01% | 322 |
|